Chief Executive Officer, Porton Biopharma
Ian Muir, holds a PhD in Pharmaceutical Science and has over 25 years’ experience in the pharmaceutical industry working in senior positions for Wyeth, Catalent, Aesica and Famar Pharmaceuticals and most recently as an advisor around M&A for financial and industry investors.
With significant leadership experience in roles located in Europe, the US and Australia, he has been responsible for leading both R&D activities, commercial and manufacturing operations globally.
20 May 2021
CATCH UP ON DEMAND
23 September 2021
BOOK YOUR PLACE NOW